• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Future development of gastrointestinal cancer incidence and mortality rates in Switzerland: a tumour registry- and population-based projection up to 2030.
 
  • Détails
Titre

Future development of gastrointestinal cancer incidence and mortality rates in Switzerland: a tumour registry- and population-based projection up to 2030.

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Swiss Medical Weekly  
Auteur(s)
Joliat, G.R.
Auteure/Auteur
Hahnloser, D.
Auteure/Auteur
Demartines, N.
Auteure/Auteur
Schäfer, M.
Auteure/Auteur
Liens vers les personnes
Mathys, Christelle  
Demartines, Nicolas  
Hahnloser, Dieter  
Schafer, Markus  
Joliat, Gaëtan-Romain  
Liens vers les unités
Chirurgie viscérale  
ISSN
1424-3997
Statut éditorial
Publié
Date de publication
2015-09
Volume
145
Numéro
145
Première page
w14188
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article Publication Status: epublish
Résumé
QUESTIONS UNDER STUDY: Since tumour burden consumes substantial healthcare resources, precise cancer incidence estimations are pivotal to define future needs of national healthcare. This study aimed to estimate incidence and mortality rates of oesophageal, gastric, pancreatic, hepatic and colorectal cancers up to 2030 in Switzerland.
METHODS: Swiss Statistics provides national incidences and mortality rates of various cancers, and models of future developments of the Swiss population. Cancer incidences and mortality rates from 1985 to 2009 were analysed to estimate trends and to predict incidence and mortality rates up to 2029. Linear regressions and Joinpoint analyses were performed to estimate the future trends of incidences and mortality rates.
RESULTS: Crude incidences of oesophageal, pancreas, liver and colorectal cancers have steadily increased since 1985, and will continue to increase. Gastric cancer incidence and mortality rates reveal an ongoing decrease. Pancreatic and liver cancer crude mortality rates will keep increasing, whereas colorectal cancer mortality on the contrary will fall. Mortality from oesophageal cancer will plateau or minimally increase. If we consider European population-standardised incidence rates, oesophageal, pancreatic and colorectal cancer incidences are steady. Gastric cancers are diminishing and liver cancers will follow an increasing trend. Standardised mortality rates show a diminution for all but liver cancer.
CONCLUSIONS: The oncological burden of gastrointestinal cancer will significantly increase in Switzerland during the next two decades. The crude mortality rates globally show an ongoing increase except for gastric and colorectal cancers. Enlarged healthcare resources to take care of these complex patient groups properly will be needed.
Sujets

Aged

Cost of Illness

Female

Forecasting

Gastrointestinal Neop...

Gastrointestinal Neop...

Humans

Incidence

Male

Middle Aged

Mortality/trends

Switzerland/epidemiol...

PID Serval
serval:BIB_B0F65EBA824F
DOI
10.4414/smw.2015.14188
PMID
26376322
WOS
000368540700006
Permalien
https://iris.unil.ch/handle/iris/140462
Open Access
Oui
Date de création
2016-02-02T15:19:56.651Z
Date de création dans IRIS
2025-05-20T21:39:57Z
Fichier(s)
En cours de chargement...
Vignette d'image
Nom

26376322.pdf

Version du manuscrit

published

Taille

748.75 KB

Format

Adobe PDF

PID Serval

serval:BIB_B0F65EBA824F.P001

URN

urn:nbn:ch:serval-BIB_B0F65EBA824F2

Somme de contrôle

(MD5):512efced3d1bb2b381b167f6133f1815

  • Copyright © 2024 UNIL
  • Informations légales